Wed Feb 19,11:55 PM ET
Here are the latest clinical trials, courtesy of CenterWatch:
A 13-month clinical research study of the use of IGIV (Intravenous Immunoglobulin-Chromatogrpahy) in Multiple Sclerosis. IGIV is currently used for treatment of MS, but has not been approved by the U.S. Food and Drug Administration (news - web sites). Males and females 18-55 with relapsing remitting MS may be eligible to participate. Research site located in New York, New York.
Please see http://www.centerwatch.com/patient/studies/cat102.html
© Copyright 2003 CenterWatch